Fetoscopic Laser Ablation for the Selective Fetal Reduction in Twin-Twin Transfusion Syndrome Stage II-IV: The Experience of a New Fetal Medicine Center

• Published in: International journal of women's health 2022-01, Vol.14, p.555-563
• Main Authors: Anh, Nguyen Duy, Hung, Ho Sy, Sim, Nguyen Thi, Ha, Nguyen Thi Thu, Nguyen, Duc Lam, Bac, Nguyen Duy, Tong, Hoang Van, Ville, Yves, Thuong, Phan Thi Huyen
• Format: Article
• Language: English
• Subjects: Ablation (Surgery); Fetofetal transfusion; Health aspects; Infants; Infants (Newborn); laser ablation; new fetal medicine center; Obstetrics; Original Research; Patient outcomes; Pregnancy; Pregnant women; selective fetal reduction; twin-twin transfusion syndrome
• ISSN: 1179-1411; 1179-1411
• DOI: 10.2147/IJWH.S350433

To evaluate the surgery outcomes of fetoscopic laser ablation (FLA) for selective umbilical cord in treating twin-twin transfusion syndrome (TTTS) with special conditions and neonatal outcomes post-operation. A prospective study, 21 monochorionic diamniotic (MCDA) twins diagnosed with TTTS stage II-IV according to Quintero classification from 16 to 26 weeks of gestation, among that, 12 cases of TTTS stage II with selective intrauterine growth restriction (sIUGR), 6 cases of TTTS stage II with proximate cord insertions, 3 cases of TTTS stage IV underwent fetoscopic laser ablation for the selective fetal reduction at Hanoi Obstetrics and Gynecology Hospital from September 2019 to July 2021. Complications and surgical outcomes were noted. Prenatal care was carried out every 2 weeks post operation until birth. Newborn neurologic complications were assessed at birth, three months, and six months after birth using Denver II test and magnetic resonance imaging (MRI). The mean gestational age at operation was 20.30 weeks. The average operation duration was 39.52 minutes. No complications of operation, such as bleeding or infection, were recorded. The mean gestational age at birth was 34.70 ± 4.33 weeks, with a mean duration of 12.97 ± 6.87 weeks between intervention and delivery. The survival rate of newborns after the operation was 90.48%. There were two stillbirths (9.52%) within seven days after the operation. No short-term neurological complications have been reported with follow-up of the newborn to 6 months after birth. Our study showed that fetoscopic laser ablation of selected fetal reduction surgery for treatment of special conditions of TTTS had no complications of operation, high neonatal survival result (90.48%), no short-term neurological complications. This should be considered for TTTS in cases of indication.